| Dr Bernard A Feigenbaum, MD | |
|
9850 Genesee Ave, 355, La Jolla, CA 92037-1224 | |
| (619) 291-5800 | |
| (866) 903-3908 |
| Full Name | Dr Bernard A Feigenbaum |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology |
| Location | 9850 Genesee Ave, La Jolla, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639115652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 5332910 (New York) | Primary |
| 207K00000X | Allergy & Immunology | G69281 (California) | Secondary |
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
The five-member board overseeing California's online insurance marketplace unanimously turned down President Obama's call to let insurers continue some health plans that don't meet the health law's requirements. Marketplace officials for Covered California also detailed who has signed up for coverage in the marketplace.
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.
Scientists at the University of Leeds are joining the global fight to eradicate polio by developing a new type of vaccine that can trick the body to develop immunity against the disease.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Medicare Part D) added prescription drug coverage to Medicare beginning in January 2006.
Biomira Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein that controls the transcription of a number of genes whose products are important for tumor growth and survival.
› Verified 7 days ago
| Entity Name | San Diego Allergy Asthma & Immunology Consultants Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013356468 PECOS PAC ID: 8224270236 Enrollment ID: O20130803000158 |
News Archive
The five-member board overseeing California's online insurance marketplace unanimously turned down President Obama's call to let insurers continue some health plans that don't meet the health law's requirements. Marketplace officials for Covered California also detailed who has signed up for coverage in the marketplace.
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.
Scientists at the University of Leeds are joining the global fight to eradicate polio by developing a new type of vaccine that can trick the body to develop immunity against the disease.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Medicare Part D) added prescription drug coverage to Medicare beginning in January 2006.
Biomira Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein that controls the transcription of a number of genes whose products are important for tumor growth and survival.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bernard A Feigenbaum, MD 9850 Genesee Ave, 355, La Jolla, CA 92037-1224 Ph: (619) 291-5800 | Dr Bernard A Feigenbaum, MD 9850 Genesee Ave, 355, La Jolla, CA 92037-1224 Ph: (619) 291-5800 |
News Archive
The five-member board overseeing California's online insurance marketplace unanimously turned down President Obama's call to let insurers continue some health plans that don't meet the health law's requirements. Marketplace officials for Covered California also detailed who has signed up for coverage in the marketplace.
MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") provides consumer-controlled Personal Health Records ("PHRs") (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), today announced that it has launched a new subscriber Program to reimburse up to $5,000 for remaining medical insurance deductibles, or out-of-pocket medical expenses up to $5,000, for a MyMedicalRecords PHR subscriber family member who has a confirmed case of the H1N1 (Swine Flu) virus.
Scientists at the University of Leeds are joining the global fight to eradicate polio by developing a new type of vaccine that can trick the body to develop immunity against the disease.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Medicare Part D) added prescription drug coverage to Medicare beginning in January 2006.
Biomira Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein that controls the transcription of a number of genes whose products are important for tumor growth and survival.
› Verified 7 days ago
Dr. Donald D. Stevenson, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-764-9010 | |
Stephen Ira Wasserman, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 9350 Campus Point Dr, Suite 2a, La Jolla, CA 92037 Phone: 858-657-8322 Fax: 858-534-7517 | |
Dr. Arthur Kavanaugh, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 9350 Campus Point Dr, Mail Code 0997, La Jolla, CA 92037 Phone: 858-657-7044 Fax: 858-657-7045 | |
Dr. Edsel Misael Abud, MD, PHD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-3200 |